Prostate International
Overview
Prostate International is a scientific journal, published since 2012 in English. The journal's country of origin is South Korea.
Details
Details
Abbr.
Prostate Int
Start
2012
End
Continuing
Frequency
Four no. a year
p-ISSN
2287-8882
e-ISSN
2287-903X
Country
South Korea
Language
English
Metrics
Metrics
h-index / Ranks: 11552
24
SJR / Ranks: 3878
989
CiteScore / Ranks: 6699
4.00
JIF / Ranks: 3481
3.0
Recent Articles
11.
Hur K, Bae W, Ha U, Kim S, Piao J, Jeon K, et al.
Prostate Int
. 2024 Dec;
12(4):195-200.
PMID: 39735201
Purpose: This study aimed to investigate the efficacy and safety of extracorporeal shock wave therapy (ESWT) over an 8-week period in individuals diagnosed with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)...
12.
Li W, Xu H, Shang W, Hong G
Prostate Int
. 2024 Dec;
12(4):201-206.
PMID: 39735200
Purpose: In this study, we aimed to validate and compare three scoring systems based on biparametric magnetic resonance imaging (bpMRI) for the detection of clinically significant prostate cancer (csPCa) in...
13.
Yuk H, Kim M, Keam B, Ku J, Kwak C, Jeong C
Prostate Int
. 2024 Dec;
12(4):219-223.
PMID: 39735199
Background: To compare the efficacy and toxicity of docetaxel treatment regimens in metastatic castration-resistant prostate cancer (mCRPC). Methods: We retrospectively analyzed 162 patients diagnosed with mCRPC who underwent docetaxel chemotherapy...
14.
Hayakawa N, Mizuno R, Tanaka T, Shiraishi Y, Matsumoto K, Kosaka T, et al.
Prostate Int
. 2024 Dec;
12(4):231-237.
PMID: 39735198
Introduction: Adverse events, such as erectile dysfunction (ED) and lower urinary tract symptoms (LUTS), are significant concerns in prostate cancer (PCa) patients treated with Iodine 125 (I-125) low-dose rate (LDR)...
15.
Lee H, Song S, Lee H, Hong S
Prostate Int
. 2024 Dec;
12(4):213-218.
PMID: 39735197
Background: Focal therapy is considered one of the treatment options for localized prostate cancer (PCa), particularly for low or very-low-risk patients. In this study, we compared the mid-term oncological outcomes...
16.
Chen C, Briggs L, Koelker M, Stone B, Alkhatib K, Labban M, et al.
Prostate Int
. 2024 Dec;
12(4):207-212.
PMID: 39735196
Background: The impact of behavioral habits such as exercise on the physical health of prostate cancer (PCa) patients is poorly understood. We aimed to investigate PCa patients' exercise habits and...
17.
Kyaw L, Lim Q, Law Y, Ong C, Loke W, Chiong E, et al.
Prostate Int
. 2024 Dec;
12(4):186-194.
PMID: 39735195
Background: Prostate cancer is now one of the most prevalent cancers in men in Asia. As the average life expectancy of Asian males with prostate cancer increases with the availability...
18.
Choi J, Yang Y, Lee C, Kim J, Kim J, Tae J, et al.
Prostate Int
. 2024 Dec;
12(4):179-185.
PMID: 39735194
Restoration of postoperative urinary continence after robot-assisted radical prostatectomy (RARP) is affected by diverse factors. We compared the pad-free and positive margin rates of patients who underwent RARP with or...
19.
Lee J, Lee C, Song W, Kang M, Sung H, Jeong B, et al.
Prostate Int
. 2024 Nov;
12(3):134-138.
PMID: 39498351
Objective: To analyze the outcomes of transperineal template-guided mapping biopsy (TTMB) in biopsy-naïve men with multiparametric magnetic resonance imaging (mpMRI) results of Prostate Imaging-Reporting and Data System (PI-RADS) 1-2. Patients...
20.
Chung Y, Song S, Lee H, Park J, Hong S
Prostate Int
. 2024 Jul;
12(2):90-95.
PMID: 39036762
Purpose: We sought to determine the association between the pre-radiation therapy prostate-specific antigen (pre-RT PSA) 0.5 and RT failure in post-radical prostatectomy (post-RP) patients. Our study also investigated the prognostic...